Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
$359.50M
Dr. Todd C. Brady M.D., Ph.D.
15.00
Lexington, MA
May 02, 2014
-9.45
$-0.64
1.12
4.41
-9,645.34%
-9.07
-0.01
3.49
874.78
4.41
-30.04%
-33.33%
Similar stocks (19)
Blueprint Medicines Corporation
BPMC
ImmunityBio, Inc.
IBRX
Structure Therapeutics Inc.
GPCR
Ardelyx, Inc.
ARDX
Viridian Therapeutics, Inc.
VRDN
Phathom Pharmaceuticals, Inc.
PHAT
Tarsus Pharmaceuticals, Inc.
TARS
Day One Biopharmaceuticals, Inc.
DAWN
Travere Therapeutics, Inc.
TVTX
Cullinan Oncology, Inc.
CGEM
89bio, Inc.
ETNB
Terns Pharmaceuticals, Inc.
TERN
Lexicon Pharmaceuticals, Inc.
LXRX
Inozyme Pharma, Inc.
INZY
Seres Therapeutics, Inc.
MCRB
HOOKIPA Pharma Inc.
HOOK
Eton Pharmaceuticals, Inc.
ETON
X4 Pharmaceuticals, Inc.
XFOR
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (28)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.823%
iShares Micro-Cap ETF
IWC
0.08447%
iShares Russell 2000 Value ETF
IWN
0.02154%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.02%
iShares Russell 2000 ETF
IWM
0.01243%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
Dimensional U.S. Small Cap ETF
DFAS
0.008334%
ProShares Ultra Russell2000
UWM
0.004664351816253219%
iShares Russell 2000 Growth ETF
IWO
0.00349%
ALPS Medical Breakthroughs ETF
SBIO
0.0026%
ProShares UltraPro Russell2000
URTY
0.0022982667909382097%
ProShares Hedge Replication ETF
HDG
0.0019514106222914627%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
8.6e-4%
iShares Russell 3000 ETF
IWV
6.5e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (19)
Blueprint Medicines Corporation
BPMC
ImmunityBio, Inc.
IBRX
Structure Therapeutics Inc.
GPCR
Ardelyx, Inc.
ARDX
Viridian Therapeutics, Inc.
VRDN
Phathom Pharmaceuticals, Inc.
PHAT
Tarsus Pharmaceuticals, Inc.
TARS
Day One Biopharmaceuticals, Inc.
DAWN
Travere Therapeutics, Inc.
TVTX
Cullinan Oncology, Inc.
CGEM
89bio, Inc.
ETNB
Terns Pharmaceuticals, Inc.
TERN
Lexicon Pharmaceuticals, Inc.
LXRX
Inozyme Pharma, Inc.
INZY
Seres Therapeutics, Inc.
MCRB
HOOKIPA Pharma Inc.
HOOK
Eton Pharmaceuticals, Inc.
ETON
X4 Pharmaceuticals, Inc.
XFOR
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (28)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.823%
iShares Micro-Cap ETF
IWC
0.08447%
iShares Russell 2000 Value ETF
IWN
0.02154%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.02%
iShares Russell 2000 ETF
IWM
0.01243%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
Vanguard Russell 2000 Value Index Fund
VTWV
0.01%
Dimensional U.S. Small Cap ETF
DFAS
0.008334%
ProShares Ultra Russell2000
UWM
0.004664351816253219%
iShares Russell 2000 Growth ETF
IWO
0.00349%
ALPS Medical Breakthroughs ETF
SBIO
0.0026%
ProShares UltraPro Russell2000
URTY
0.0022982667909382097%
ProShares Hedge Replication ETF
HDG
0.0019514106222914627%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
8.6e-4%
iShares Russell 3000 ETF
IWV
6.5e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Growth Index Fund
VTWG
0%
Vanguard Extended Market Index Fund
VXF
0%